Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin adjustment protocol versus usual physician adjustment during hemodialysis in adults with type 2 diabetes and end-stage kidney disease
TCTR20261027007Phase 2Active, not recruiting
- Sponsor
- Thammasat University
- Start
- Oct 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of human insulin in type 2 diabetes mellitus (T2DM), sponsored by Thammasat University. Started Oct 2026; status: active, not recruiting.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20261027007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261027007.